What is Genenta Science SpA ADR's share price today?
Genenta Science SpA ADR (GNTA) share price today is $0.59 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $0.63 and a day low of $0.59.What exchange does Genenta Science SpA ADR stock trade on, and under what ticker symbol?
Genenta Science SpA ADR stock trades on NASDAQ under the ticker symbol GNTA.What is Genenta Science SpA ADR's market capitalization?
Genenta Science SpA ADR's market capitalization is $30.37M as of October 27, 2026 at 1:29 AM IST.What is Genenta Science SpA ADR's price-to-earnings (P/E) ratio?
Genenta Science SpA ADR's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.What is Genenta Science SpA ADR's price-to-book (P/B) ratio?
Genenta Science SpA ADR's price-to-book (P/B) ratio is 1.45 as of October 26, 2026.Can Indian investors buy Genenta Science SpA ADR shares?
Yes, You can buy Genenta Science SpA ADR shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Genenta Science SpA ADR shares from India?
Indian investors can buy Genenta Science SpA ADR shares in three steps: 1. Search Genenta Science SpA ADR on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Genenta Science SpA ADR shares for Indian investors?
Since Genenta Science SpA ADR trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Genenta Science SpA ADR shares via Tickertape?
Indian investors can start investing in Genenta Science SpA ADR (GNTA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 16.8634 shares at the current price of $0.59.
$
₹
$0.595.88% (-0.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
1.45
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-0.37
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on consolidated analysts reports
Buy, Sell and Hold recommendations are not available
Price Upside
+1007.78%
Earnings Growth
—
Rev. Growth
—
Company Profile
Company Profile
ABBV
P/E Ratio
80.68
80.68
1Y Return
24.94%
24.94%
Buy Reco %
80.00
80.00
AMGN
P/E Ratio
27.28
27.28
1Y Return
51.04%
51.04%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
29.23%
29.23%
Buy Reco %
78.57
78.57
P/E Ratio
29.90
29.90
1Y Return
23.96%
23.96%
Buy Reco %
81.25
81.25
MRNA
P/E Ratio
—
—
1Y Return
662.28%
662.28%
Buy Reco %
21.73
21.73
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$0.63Baseline
Analyst Target - 1 year
Target$6.98+1007.78%
All values in $
2026
Current$0.63Baseline
Analyst Target - 1 year
Target$6.98+1007.78%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2024
Q3 2025
Q4 2025
Q1 2026
Revenue
Net Income
| Financial Year | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q2 2024 | Q4 2024 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | -0.02 | - | -0.02 | -0.02 | -0.02 | -0.01 | - | -0.01 |
| Net Income | - | -6.36 | -6.69 | -0 | -4.80 | -4.06 | -5.09 | -3.56 | - | -2.68 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
IndustrialsConglomerates
IndustrialsConglomerates
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Genenta Science SpA ADR | - | 1.45 | - |
| AbbVie Inc | 80.68 | 50.45 | 0.53 |
| Amgen Inc | 27.28 | 17.56 | 2.28 |
Price Comparison
Price Comparison
Compare GNTA with any stock or ETFCompare GNTA with any stock or ETF
Comparing from
GNTA
ABBV
AMGN
The 12-month consensus target implies 1007.78% growth, versus a trailing 3-year CAGR of -49.73%.